The Global Anesthesia Device Market, by Product Type (Anesthesia Monitoring Systems (Advanced Anesthesia Monitor (Anesthesia Gas Monitors, Depth of Anesthesia Monitors, Standalone Capnography Monitors, and MRI Compatible Anesthesia Monitors) and Basic Anesthesia Monitors), Anesthesia Machine (Portable Anesthesia Machine and Standalone Anesthesia Machine), Anesthesia Workstation, Anesthesia Ventilators, and Anesthesia Disposables and Accessories), by End User (Hospitals, Ambulatory Surgical Centers, and Multispecialty Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) was valued at US$ 14,977.9 million in 2022 and is expected to exhibit a CAGR of 7.6% during the forecast period (2022–2030).
Anesthesia is a medical procedure to control pain during the course of a surgery. Anesthesia monitors have been widely used in a number of healthcare organizations, clinics and outpatient surgery centers to track the patient's vital signs such as blood pressure and temperature, while they are under sedation in the operating theater. Increasing approvals from healthcare regulatory authorities for new technologies is expected to drive the market growth. For instance, in March 2019, Masimo Corp., a global medical technology company, received CE marking for its Next Generation SedLine brain function monitoring for pediatric patients. Sedline helps surgeons to monitor the state of the brain of pediatric patients under anesthesia with bilateral data acquisition and processing of four leads of electroencephalogram (EEG) signals. SedLine uses a pediatric-specific signal processing engine to improve performance of Masimo’s processed EEG parameter, the Patient State Index (PSi), when monitoring pediatric patients one year old and above.
Global Anesthesia Devices Market– Impact of Coronavirus (COVID-19) Pandemic
The coronavirus or COVID-19 outbreak started in Wuhan, China in 2019 and has spread across all the continents of the world, affecting various industries globally. The economy in countries all over the world such as India, Italy, Bangladesh, Sri Lanka, the U.S., Morocco, and others has been disrupted due to lockdowns implemented by governments to combat the spread of coronavirus since 2020.
During the COVID-19 pandemic, there was an overall decline in the need for anesthetic device as an outcome of fewer surgeries. The impact on the healthcare sector has also been profound, and the already overburdened healthcare systems around the world are were under tremendous pressure. For instance, in December 2021, a report was published in journal of medical cases, on decreases in elective and non-elective surgical case volumes during the covid-19 pandemic which reported that the American surgical system (ACS) encouraged conservative medical management of certain diseases when appropriate in COVID-positive patients and the resumption of elective operations in a staged fashion. These modifications resulted in the postponement of many elective and non-urgent surgical cases, especially at large public hospitals. This had translated to a statistically significant decrease in both elective and non-elective case volumes. The decrease in overall volumes occurred across the majority of surgical specialties, including acute care and trauma surgery, cardiothoracic surgery, ophthalmology, oral and maxillofacial surgery, neurosurgery, otolaryngology, orthopedic surgery, plastic surgery, surgical oncology, and urology.
Thus, impact of the Coronavirus (COVID-19) pandemic had hindered the growth of the global anesthesia device market during the pandemic.
Global Anesthesia Devices Market: Key Developments
Increasing product approval from the U.S. FDA (Food and Drug Administration) by the market player is expected to drive the growth of the global anesthesia device market over the forecast period. For instance, on February 28, 2022, Masimo, a global medical technology company, announced the US FDA (Food and Drug Administration) clearance of SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric electroencephalogram (EEG) Sensor. With this clearance, the potential benefits of SedLine have been expanded to all patients one year, old and above in the U.S. SedLine helps clinicians monitor brain activity bilaterally by processing electroencephalogram (EEG) signals from Masimo’s four-lead SedLine EEG sensors. This clearance brings Masimo’s bilateral brain activity monitoring to children 1 to 17 years old, in conjunction with specially sized pediatric sensors designed for easier application on smaller pediatric foreheads.
Furthermore, on July 20, 2022, Masimo, a global medical technology company, announced the results of a randomized, controlled trial published in the Journal of Clinical Anesthesia in which the ability of electroencephalogram (EEG)-guided anesthesia, using Masimo SedLine function monitoring, to decrease the amount of the drug sevoflurane needed to maintain anesthesia in paediatric patients undergoing minor surgery was examined by Dr. Melody H.Y. Long and colleagues from the KK Women's and Children's Hospital in Singapore. They discovered that using SedLine to guide anesthesia lowered the need for sevoflurane and resulted in a lower incidence of burst suppression, which has been previously linked to postoperative delirium.
Browse 30 Market Data Tables and 28 Figures spread through 172 Pages and in-depth TOC on " Global Anesthesia Device Market, by Product Type (Anesthesia Monitoring Systems (Advanced Anesthesia Monitor (Anesthesia Gas Monitors, Depth of Anesthesia Monitors, Standalone Capnography Monitors, and MRI Compatible Anesthesia Monitors) and Basic Anesthesia Monitors), Anesthesia Machine (Portable Anesthesia Machine and Standalone Anesthesia Machine), Anesthesia Workstation, Anesthesia Ventilators, and Anesthesia Disposables and Accessories), by End User (Hospitals, Ambulatory Surgical Centers, and Multispecialty Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Forecast to 2030
To know the latest trends and insights prevalent in this market, click the link below:
Key players in the market are focused on product launch for anesthesia delivery in order to enhance their market share. For instance, in November 2018, Septodont Inc., a pharmaceutical company, launched Dentapen electronic syringe for dental anesthesia. Dentapen monitors the injection with a constant flow at the right pace. This helps the dentist to focus more on needle insertion, which leads to better control of the injection and helps to reduce pain in patient.
Key Takeaways of the Global Anesthesia Devices Market: